Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00825786 · ClinicalTrials.gov registry record · Phase 3
Ultrasound Guided Supraclavicular Nerve Block
A Phase 3 study of Local Anesthetic, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 103
- Enrollment target
- 1
- Study location
NCT00825786 is a Phase 3 study of Local Anesthetic that has completed, run by The Cleveland Clinic. The registered enrollment target is 103 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00825786, a Phase 3 study of Local Anesthetic, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the hypothesis that sequential injection of 1.5% mepivacaine followed 90 seconds later by 0.5% ropivacaine in ultrasound guided supraclavicular block provides a quicker onset and a longer duration of analgesia than an equi-dose mixture of the two local anesthetics.
Conditions Studied
Interventions
- DRUG Mepivacaine
- DRUG Ropivacaine
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00825786
The ClinicalTrials.gov registry entry for NCT00825786 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Local Anesthetic appearing as the primary indexed condition, and to 2 interventions - of which Mepivacaine is the first listed.
NCT00825786 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00825786 about?
NCT00825786 is a clinical study titled "Ultrasound Guided Supraclavicular Nerve Block". This study will test the hypothesis that sequential injection of 1.5% mepivacaine followed 90 seconds later by 0.5% ropivacaine in ultrasound guided supraclavicular block provides a quicker onset and a longer duration of analgesia than an equi-dose mixture of the two local anesthetics.
What is the current status of trial NCT00825786?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 103 participants. The study started on 2008-09. Estimated completion is 2010-08.
What conditions does trial NCT00825786 study?
This clinical trial studies the following conditions: Local Anesthetic.
What interventions are being tested in trial NCT00825786?
The interventions under investigation include: Mepivacaine (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT00825786?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00825786 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.